Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA drug recalls in 2019

Every FDA drug recall initiated in 2019, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.

1,788 recalls, newest first.

Class II · Moderate risk

HCG liquid

Lack of sterility assurance.

Terminated Sterility / contamination Hiers Enterprises, LLC dba Northwest Compounding Pharmacy D-0395-2019
Class II · Moderate risk

Cefdinir for Oral Suspension USP

CGMP Deviations: Product complaints received indicating reconstituted suspension was observed to be thick.

Terminated cGMP deviation Lupin Pharmaceuticals Inc. NDC 68180-723-20 D-0376-2019
Class II · Moderate risk

Cefdinir for Oral Suspension USP

CGMP Deviations: Product complaints received indicating reconstituted suspension was observed to be thick.

Terminated cGMP deviation Lupin Pharmaceuticals Inc. NDC 68180-722-20 D-0375-2019
Class II · Moderate risk

Dianeal Low Calcium

Lack of Assurance of Sterility: Confirmed customer complaints for leaks on the tubing.

Terminated Sterility / contamination Baxter Healthcare Corporation NDC 0941-0424-52 D-0351-2019

Recalls by year